Clinical Trial Update: Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of sodium zirconium cyclosilicate (Lokelma) in patients with chronic kidney disease or moderate kidney dysfunct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Lokelma (sodium zirconium cyclosilicate)

Snippet

Sponsor: ZS Pharma, Inc. | Conditions: Hyperkalemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-06-29